MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Alka-Seltzer® Teams Up with George Kittle to Encourage Football Fans to ‘Say Yes’ to Going Big on Game Days
From Bayer
Via Business Wire
News headline image
New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
From Bayer
Via Business Wire
News headline image
New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
From Bayer
Via Business Wire
News headline image
Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer Therapies
From Bayer
Via Business Wire
News headline image
FieldView and Combyne Platform Integration Helps Farmers Better Manage Grain Marketing and Build Profitability Insights
From Bayer
Via Business Wire
News headline image
Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023
From Bayer
Via Business Wire
News headline image
Bayer and Dollar General Partner to Increase Access to Fruit and Veggies, Celebrate National School Lunch Week
From Bayer
Via Business Wire
News headline image
Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery
From Bayer
Via Business Wire
News headline image
The Menopause Society Annual Meeting 2023: Bayer to present latest real-world evidence of menopausal symptoms and their treatment
From Bayer
Via Business Wire
News headline image
Bayer’s Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology
From Bayer
Via Business Wire
News headline image
Bayer Expands Clinical Development Program Investigating Finerenone for Potential Treatment of Heart Failure
From Bayer
Via Business Wire
News headline image
Bayer and Kroger Team to Help Improve Access to Health and Nutrition in Rural America
From Bayer
Via Business Wire
News headline image
FieldView Rolls Out New Capabilities For Post-Harvest Analysis and Reporting
From Bayer
Via Business Wire
News headline image
One in Four American Adults Would Rather Not Know They Have Cancer
From Bayer
Via Business Wire
News headline image
Bayer Donates $500K to Support Maui Community After Devastating Fires
From Bayer
Via Business Wire
News headline image
The Terror is Hatching: Bayer Unveils Upcoming “Rootworm Week”
From Bayer
Via Business Wire
News headline image
Bayer Earns Top Score on 2023 Disability Equality Index
From Bayer
Via Business Wire
News headline image
Bayer and Luke Bryan Reunite for Annual #HerestotheFarmer Campaign in Support of Feeding America and Rural Communities
From Bayer
Via Business Wire
News headline image
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane
From Bayer
Via Business Wire
News headline image
FDA approves Bayer’s Ultravist® (iopromide) injection for contrast-enhanced mammography
From Bayer
Via Business Wire
News headline image
Bayer to Investigate Finerenone in Phase III Study in Adults With Chronic Kidney Disease Associated With Type 1 Diabetes
From Bayer
Via Business Wire
News headline image
Bayer Announces Senior Bayer Representative and President of Bayer U.S.
From Bayer
Via Business Wire
News headline image
Bayer Announces Changes to U.S. Country Leadership Team
From Bayer
Via Business Wire
News headline image
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics
From Bayer
Via Business Wire
News headline image
Latest Vitrakvi® (larotrectinib) Subgroup Analyses at ASCO 2023 Showcase Long-Term Efficacy and Safety Profile in Adult and Pediatric Patients with NTRK Gene Fusion Cancer, Across Solid Tumors
From Bayer
Via Business Wire
News headline image
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
From Bayer
Via Business Wire
News headline image
Bayer Launches Unit to Develop New Precision Health Consumer Products
From Bayer
Via Business Wire
News headline image
Bayer Presents New Data Across Oncology Portfolio at the 2023 ASCO Annual Meeting
From Bayer
Via Business Wire
News headline image
Bayer launches Seeing Red campaign around the treatment of Heavy Menstrual Bleeding (HMB)
From Bayer
Via Business Wire
News headline image
Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story